The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis – Data from the Romanian Hepatocellular Carcinoma Registry

Authors

  • Dana Crișan Dept. of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca Clinical Municipal Hospital, Cluj- Napoca, Romania
  • Bogdan Procopeț Dept. of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Rareș Crăciun Dept. of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Horia Ștefănescu Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Liana Gheorghe Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • Ioan Sporea Dept. of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania
  • Larisa Daniela Săndulescu Dept. of Gastroenterology, Research Center of Gastroenterology and Hepatology, Craiova University of Medicine and Pharmacy, Craiova, Romania
  • Anca Trifan Institute of Gastroenterology and Hepatology, Emergency Clinical Hospital St. Spiridon, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Zeno Spârchez Dept. of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Mirela Dănilă Dept. of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania
  • Ion Rogoveanu Dept. of Gastroenterology, Research Center of Gastroenterology and Hepatology, Craiova University of Medicine and Pharmacy, Craiova, Romania
  • Răzvan Cerban Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • Camelia Cojocariu Institute of Gastroenterology and Hepatology, Emergency Clinical Hospital St. Spiridon, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Roxana Șirli Dept. of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania
  • Cristiana Marinela Urhut Dept. of Gastroenterology, Research Center of Gastroenterology and Hepatology, Craiova University of Medicine and Pharmacy, Craiova;
  • Călin Burciu Dept. of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania
  • Lidia Ciobanu Dept. of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Mihai Rătan Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Tudor Cosma Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Nadim Al-Hajjar Dept. of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Dept. of Surgery, ”Prof. Dr.O. Fodor” Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Mircea Grigorescu Dept. of Internal Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Dept. of Gastroenterology, Prof. Dr. O. Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania

DOI:

https://doi.org/10.15403/jgld-6114

Keywords:

hepatocellular carcinoma, prognosis, biomarkers, non-invasive, inflammation scores

Abstract

Background and Aims: Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related mortality, a figure that is on the rise. The shared hallmark of different etiologies, progression, and HCC survival is chronic inflammation, making it a significant field of interest for prognostic and therapeutic strategies. We aimed to evaluate the prognostic accuracy of several inflammation-based scores in HCC.

Methods: A consecutive series of patients at their first HCC diagnosis were enrolled during a 5-year timespan in a prospectively maintained multicentric database. Demographic, clinical, biological, and imagistic data were collected. Representative inflammation-based prognostic scores, including the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic immune inflammation index (SII), prognostic nutritional index (PNI), albumin-to-bilirubin index (ALBI), platelet-albumin-bilirubin-index (PALBI), AST-to-lymphocyte ratio (ALRI), AST/ALT, AST-to-platelet ratio (APRI) were assessed for prediction of overall survival (OS) in a scenario-based setting, using Kaplan-Meier curves, univariate and multivariate analyses.

Results: A total of 467 patients from five tertiary-care hospitals were enrolled in this study. The median age was 64.94 years, and the most frequent etiology of the liver disease was hepatitis C (50%). During a median of 14.85 (35) months of follow-up, the cumulative mortality was 84.8%. In the univariate analysis, PNI (HR=2.414; p=0.021), ALBI grade (HR=2.023; p<0.001), and PALBI grade (HR=2.022; p<0.001) demonstrated the highest prognostic accuracies for OS in HCC, regardless of the clinical scenario. Moreover, PLR (HR=1.635; p=0.002), ALRI (HR=1.555; p<0.001), NLR (HR=1.461; p=0.007), AST/ALT (HR=1.420; p=0.012), and APRI (HR=1.356; p=0.009) were also significant prognostic factors for OS. The multivariate analysis showed that only ALBI grade (HR=1.974; p<0.001), SII (HR=1.487; p=0.009), and PLR (HR=1.647; p=0.014) were independently associated with OS.

Conclusions: Inflammation-based scores allow for an accurate prediction of survival in HCC. Their ability to predict the response to treatment and complications merits further investigation.

Downloads

Published

2025-06-28

How to Cite

1.
Crișan D, Procopeț B, Crăciun R, Ștefănescu H, Gheorghe L, Sporea I, Săndulescu LD, Trifan A, Spârchez Z, Dănilă M, Rogoveanu I, Cerban R, Cojocariu C, Șirli R, Urhut CM, Burciu C, Ciobanu L, Rătan M, Cosma T, Al-Hajjar N, Grigorescu M. The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis – Data from the Romanian Hepatocellular Carcinoma Registry. JGLD [Internet]. 2025 Jun. 28 [cited 2026 Jan. 14];34(2):205-13. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/6114

Issue

Section

Original Article